Comparison of a Speech-Language Assessment Tool for Pragmatic and Discourse Skills in Schizophrenia Spectrum Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-06

Study Completion Date

2024-02-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The scientific literature has largely objectified language disorders in schizophrenia. And more precisely, the impairment of pragmatic and discursive language skills. Currently, there is no standardized language assessment tool specific to these patients. The aim of this study is to compare the effectiveness of a newly developed speech-language assessment tool for pragmatic and discourse skills for patients suffering from schizophrenia .

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis

NCT06036316

Psychosis Schizophrenia At-risk Mental State +1 more

RECRUITING NA

Study on Communication Comprehension in the Schizophrenic Spectrum

NCT03225027

Schizophrenia Simple

COMPLETED NA

Semantic and Syntactic Computerized Analysis of Free Speech

NCT03525054

Psychotic Disorders Psychosis Schizophrenia and Related Disorders +2 more

RECRUITING

Linguistic Predictors of Outcomes in Psychosis

NCT05601050

Schizophrenia and Related Disorders

COMPLETED

The Efficacy of Speech Competition Training on Auditory Hallucination in Schizophrenia

NCT05850923

Auditory Hallucination

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The scientific literature has largely objectified language disorders in schizophrenia. And more precisely, the impairment of pragmatic and discursive language skills. Currently, there is no standardized language assessment tool specific to these patients. The aim of this study is to compare the effectiveness of a newly developed speech-language assessment tool for pragmatic and discourse skills for patients suffering from schizophrenia.

To do so, patients will have to pass six tests: three tests of the new tool and three corresponding gold standard tests. The first two tests will assess pragmatic skills by means of a semi-directed interview. The next two tests will assess discourse skills through two image description tasks. Finally, the last two tests will evaluate narrative skills through the oral restitution of two heard texts.

The main objective is to compare the performance of schizophrenic patients detected in the pathological zone with the scales of the new tool versus the gold standard scales.

The secondary objective is to determine which skills are most affected by comparing patients' scores in pragmatic skills versus those in discourse skills.

This tool would allow to precisely objectify language disorders and to optimize the multidisciplinary diagnosis and care of patients suffering from schizophrenia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychotic Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

diagnostic

all patients have the study test

Group Type EXPERIMENTAL

Measurement of pragmatic and discourse test scores in the two scales.

Intervention Type DIAGNOSTIC_TEST

The aim of this study is to compare the effectiveness of a newly developed speech-language assessment tool for pragmatic and discourse skills for patients suffering from schizophrenia .

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Measurement of pragmatic and discourse test scores in the two scales.

The aim of this study is to compare the effectiveness of a newly developed speech-language assessment tool for pragmatic and discourse skills for patients suffering from schizophrenia .

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female between the ages of 18 and 60
* Patient with a diagnosis of schizophrenic spectrum disorder and other psychotic disorders meeting DSM V criteria
* Patient who has been clinically and treatment stable for at least three months
* Patient who can read and write French
* Patient who is a beneficiary of a social security plan or similar
* Patient with ability to sign free and informed consent

Exclusion Criteria

* \- Patient hospitalized under restraint
* Patient under guardianship
* Patient who has stopped taking his or her treatment
* Patient who had a change in treatment in the period of less than three months prior to the pass
* Patient with a worsening of the disease in the three months prior to the inclusion visit

Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No